{"meta":{"query_hash":"08362b53c802","filters":{"venue":"Journal of Drug Delivery"},"cohort_total":3,"direct_labels_cover":0,"predictions_cover":3,"exported":3,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/08362b53c802","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Drug+Delivery"},"results":[{"id":"W2042519261","doi":"10.1155/2011/349206","title":"The Use of Radioactive Marker as a Tool to Evaluate the Drug Release in Plasma and Particle Biodistribution of Block Copolymer Nanoparticles","year":2011,"lang":"en","type":"article","venue":"Journal of Drug Delivery","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celator Pharmaceuticals (Canada)","funders":"","keywords":"Prodrug; Biodistribution; Nanoparticle; Paclitaxel; Copolymer; Drug; Chemistry; In vivo; Drug carrier; Particle size; Nanotechnology; Drug delivery; Materials science; Pharmacology; Organic chemistry; In vitro; Chemotherapy; Biochemistry; Medicine; Surgery","score_opus":0.026136601189996316,"score_gpt":0.2398284408629726,"score_spread":0.21369183967297628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042519261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980109,0.00066882884,0.000010381127,0.0007195625,0.00022857319,0.00030160093,0.00003910478,0.000007502579,0.000013599358],"genre_scores_gemma":[0.9991606,0.00014625632,0.00049147045,0.00011172165,0.00003285512,0.000009430708,3.006598e-7,0.0000128194215,0.00003454499],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972219,0.0006258255,0.0009795827,0.00019292784,0.0006005668,0.00037921892],"domain_scores_gemma":[0.99751776,0.0009437239,0.00054278417,0.00034856648,0.00048700772,0.00016017827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023620096,0.00016911924,0.00033956673,0.000092573166,0.00014246788,0.000066413515,0.00034277161,0.000040386592,0.00007408921],"category_scores_gemma":[0.0005965133,0.00010192821,0.00011713174,0.0003700175,0.0003594107,0.0006001314,0.0001419348,0.0001669108,0.000029724768],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039762035,0.00033338577,0.0074850833,0.000017800852,0.00005642939,0.00004274459,0.0035844867,0.00056298805,0.9802354,0.00020025915,0.0013716468,0.0021335748],"study_design_scores_gemma":[0.0012798492,0.00023109435,0.010345441,0.00011513829,0.00012466637,0.000049749564,0.00122557,0.0015702621,0.98449206,0.00024688593,0.00018859668,0.00013070078],"about_ca_topic_score_codex":0.0006161596,"about_ca_topic_score_gemma":0.0001302194,"teacher_disagreement_score":0.0042566485,"about_ca_system_score_codex":0.00009719079,"about_ca_system_score_gemma":0.00022933207,"threshold_uncertainty_score":0.4156512},"labels":[],"label_agreement":null},{"id":"W2171891111","doi":"10.1155/2012/686108","title":"Cationic Albumin Nanoparticles for Enhanced Drug Delivery to Treat Breast Cancer: Preparation and <i>In Vitro</i> Assessment","year":2011,"lang":"en","type":"article","venue":"Journal of Drug Delivery","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research; Faculty of Medicine, McGill University; Natural Sciences and Engineering Research Council of Canada; McGill University","keywords":"Polyethylenimine; Doxorubicin; Biocompatibility; Zeta potential; Cytotoxicity; Cardiotoxicity; Pharmacology; Chemistry; Albumin; Transfection; Nanoparticle; Drug delivery; Human serum albumin; Serum albumin; Bovine serum albumin; Drug; Drug carrier; In vitro; Medicine; Materials science; Nanotechnology; Toxicity; Chemotherapy; Biochemistry; Surgery; Organic chemistry","score_opus":0.012874129955913319,"score_gpt":0.26517609018939936,"score_spread":0.25230196023348606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171891111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99716043,0.0006720911,0.00024927114,0.00065552583,0.0004935724,0.00057041924,0.00010484842,0.000029926838,0.000063897074],"genre_scores_gemma":[0.9930679,0.0002458443,0.005955253,0.0003150177,0.00018623962,0.000100317084,0.000003372126,0.000031456922,0.00009455572],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99742734,0.00020680999,0.00095328223,0.00039678862,0.00045224716,0.00056350464],"domain_scores_gemma":[0.99805164,0.00024789723,0.00053893024,0.00027875448,0.00055517344,0.00032757758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012613366,0.000261789,0.0004778823,0.00028495843,0.00015447964,0.000113615926,0.00032707248,0.000061881656,0.00010438351],"category_scores_gemma":[0.000038072674,0.00023821801,0.0001281711,0.00028004873,0.00008783501,0.0011066208,0.00009009164,0.00014194977,0.000028408136],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002608736,0.0003564129,0.00088078383,0.000054287822,0.000019258325,0.00001777791,0.0026107533,0.00064943,0.98793966,0.000013511436,0.0012297878,0.0036195966],"study_design_scores_gemma":[0.0018770667,0.00017674026,0.0043233535,0.00014567637,0.00011880222,0.000046224803,0.0005714599,0.00064712606,0.9915713,0.00017476223,0.00007568532,0.0002718079],"about_ca_topic_score_codex":0.00062893744,"about_ca_topic_score_gemma":0.00062397117,"teacher_disagreement_score":0.0057059815,"about_ca_system_score_codex":0.00049378583,"about_ca_system_score_gemma":0.00053285935,"threshold_uncertainty_score":0.9714248},"labels":[],"label_agreement":null},{"id":"W2777846841","doi":"10.1155/2017/9090325","title":"Targeted Therapeutic Nanoparticles: An Immense Promise to Fight against Cancer","year":2017,"lang":"en","type":"review","venue":"Journal of Drug Delivery","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Nanomedicine; Nanotechnology; PLGA; PEGylation; Cancer therapy; Computer science; Drug delivery; Polyethylene glycol; Cancer; Nanoparticle; Materials science; Medicine; Chemistry","score_opus":0.06320962018428887,"score_gpt":0.3439974211019036,"score_spread":0.28078780091761474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2777846841","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18474698,0.81212556,0.0000053337217,0.00019768324,0.0019385413,0.00075289345,0.00015594589,0.00004750007,0.000029572695],"genre_scores_gemma":[0.0062556984,0.9908738,0.0005208828,0.0006969654,0.0010739928,0.00008788286,0.000010047918,0.00014271587,0.0003379814],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946,0.0008394543,0.0019833026,0.00064313493,0.0010011973,0.0009329171],"domain_scores_gemma":[0.9942296,0.00026962857,0.002673332,0.0012224669,0.0007451538,0.00085980725],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021156701,0.0007315797,0.0025058386,0.0005010718,0.00036490333,0.00051733723,0.0019471829,0.00025717317,0.00043434184],"category_scores_gemma":[0.00017762781,0.00053859764,0.00080186594,0.00032138426,0.00014945118,0.001169318,0.00024788105,0.0006218436,0.0007037037],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032818687,0.000629752,0.000010621709,0.002675818,0.00033602616,0.0008370932,0.0008789536,0.0002263193,0.12606925,0.000006521364,0.009354904,0.8586466],"study_design_scores_gemma":[0.001004388,0.00036197237,0.000007819061,0.012685049,0.0015915878,0.00014116552,0.000098868884,0.000049008642,0.034547605,0.000029215353,0.94850063,0.0009827124],"about_ca_topic_score_codex":0.00006127824,"about_ca_topic_score_gemma":0.000047219135,"teacher_disagreement_score":0.9391457,"about_ca_system_score_codex":0.000669434,"about_ca_system_score_gemma":0.002195252,"threshold_uncertainty_score":0.99970657},"labels":[],"label_agreement":null}]}